Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VBIV

VBI Vaccines (VBIV) Stock Price, News & Analysis

VBI Vaccines logo

About VBI Vaccines Stock (NASDAQ:VBIV)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.02
$0.79
52-Week Range
N/A
Volume
29.90 million shs
Average Volume
3.66 million shs
Market Capitalization
$1.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VBIV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VBI Vaccines and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VBIV Stock News Headlines

Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.tc pixel
Why Is VBI Vaccines (VBIV) Stock Up 62% Today?
See More Headlines

VBIV Stock Analysis - Frequently Asked Questions

VBI Vaccines Inc. (NASDAQ:VBIV) issued its quarterly earnings data on Monday, March, 13th. The biopharmaceutical company reported ($1.60) earnings per share for the quarter, missing the consensus estimate of ($1.40) by $0.20. The biopharmaceutical company earned $0.29 million during the quarter, compared to the consensus estimate of $1.98 million. VBI Vaccines had a negative net margin of 881.79% and a negative trailing twelve-month return on equity of 525.42%.

VBI Vaccines's stock reverse split on the morning of Wednesday, April 12th 2023.The 1-20 reverse split was announced on Wednesday, April 12th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, April 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that VBI Vaccines investors own include Inovio Pharmaceuticals (INO), Vaxart (VXRT), NVIDIA (NVDA), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Pfizer (PFE) and Novavax (NVAX).

Company Calendar

Last Earnings
3/13/2023
Today
8/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VBIV
CIK
764195
Fax
N/A
Employees
22
Year Founded
2001

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$92.84 million
Net Margins
-881.79%
Pretax Margin
-881.79%
Return on Equity
-525.42%
Return on Assets
-45.87%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.34
Quick Ratio
0.21

Sales & Book Value

Annual Sales
$9.41 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.32 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
28,682,000
Free Float
25,713,000
Market Cap
$1.87 million
Optionable
Optionable
Beta
2.18

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:VBIV) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners